Downregulation of SF3B2 protects CNS neurons in models of multiple sclerosis.

Ye Eun JeongLabchan RajbhandariByung Woo KimArun VenkatesanAhmet Hoke

Published in: Annals of clinical and translational neurology (2022)

Together, these findings suggest that the downregulation of SF3B2 is a novel potential therapeutic target to prevent secondary neurodegeneration in MS.

Keyphrases

multiple sclerosis
cell proliferation
signaling pathway
white matter
spinal cord
ms ms
spinal cord injury